<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> is a <z:e sem="disease" ids="C1535926" disease_type="Mental or Behavioral Dysfunction" abbrv="">neurodevelopmental disorder</z:e> characterized by <z:hpo ids='HP_0010864'>mental retardation, severe</z:hpo> <z:hpo ids='HP_0002167'>speech disorder</z:hpo>, <z:hpo ids='HP_0001999'>facial dysmorphism</z:hpo>, secondary <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:hpo ids='HP_0001251'>ataxia</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, and <z:mp ids='MP_0004924'>abnormal behaviors</z:mp> such as easily provoked laughter </plain></SENT>
<SENT sid="1" pm="."><plain>It is most frequently caused by a de novo maternal deletion of chromosome 15q11-q13 (about 70-90%), but can also be caused by paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> of chromosome 15q11-q13 (3-7%), an imprinting defect (2-4%) or in mutations in the ubiquitin protein ligase E3A gene UBE3A mostly leading to frame shift mutation </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, for patients with overlapping clinical features (Angelman-like syndrome), mutations in <z:chebi fb="36" ids="29309">methyl</z:chebi>-CpG binding protein 2 gene MECP2 and cyclin-dependent kinase-like 5 gene CDKL5 as well as a microdeletion of 2q23.1 including the <z:chebi fb="36" ids="29309">methyl</z:chebi>-CpG binding domain protein 5 gene MBD5 have been described </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we describe a patient who carries a de novo 5Mb-deletion of chromosome 15q11.2-q13.1 known to be associated with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> and a further, maternally inherited deletion 2q21.3 (~364kb) of unknown significance </plain></SENT>
<SENT sid="4" pm="."><plain>In addition to classic features of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, she presented with severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in the first year of life, a symptom that has not been described in patients with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The 15q11.2-q13.1 deletion contains genes critical for Prader-Willi syndrome, the <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> causing genes UBE3A and ATP10A/C, and several non-imprinted genes: GABRB3 and GABRA5 (both encoding subunits of <z:chebi fb="3" ids="16865">GABA</z:chebi> A receptor), GOLGA6L2, HERC2 and OCA2 (associated with oculocutaneous <z:hpo ids='HP_0001022'>albinism</z:hpo> II) </plain></SENT>
<SENT sid="6" pm="."><plain>The deletion 2q21.3 includes exons of the genes RAB3GAP1 (associated with Warburg Micro syndrome) and ZRANB3 (not disease-associated) </plain></SENT>
<SENT sid="7" pm="."><plain>Despite the <z:mp ids='MP_0002873'>normal phenotype</z:mp> of the mother, the relevance of the 2q21.3 microdeletion for the phenotype of the patient cannot be excluded, and further case reports will need to address this point </plain></SENT>
</text></document>